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Abstract
In this dissertation, I develop statistical methods to address three important sci-
entific problems. A common theme behind these methods is the stitching together of
multiple data sources to address the scientific questions of interest. In the first paper
(Chapter 2), I propose a novel statistical framework to learn about the association
between a secondary outcome (e.g., obesity) and a genetic risk factor (e.g., ORMDL3
locus on Chromosome 17) from a genetic case-control study based on asthma. The
method involves the use of asthma prevalence information from a relevant sample
survey. In the second paper (Chapter 3), I develop a method to evaluate whether
there are adverse health consequences of kidney donation. To address this ques-
tion, I use data on donors from the Wellness and Health Outcomes in LivE Donors
(WHOLE-DONOR) Study and on healthy non-donors from the Atherosclerosis Risk
in Communities (ARIC) and Coronary Artery Risk Development in Young Adults
(CARDIA) studies. In the third paper (Chapter 4), I propose a covariate-adjusted
method for testing the difference between two treatment groups where the measured
outcome is a function. The proposed method utilizes information from repeated mea-
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sures of daily oxygen consumption function and scalar body composition measures
(e.g., lean mass, fat mass) on two groups of mice, one with and one without a specific
gene.
Primary Readers: Daniel O. Scharfstein, Ciprian M. Crainiceanu, Allan Massie
and Eliseo Guallar
Secondary Readers: Michael Rosenblum and Ramin Mojtabai.
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Multiple data sources are often required to address important scientific questions.
A single data source is often insufficient to estimate a target parameter of interest. A
classic example is in genetic epidemiology where interest focuses on the causal effect
of a biomarker (e.g. Vitamin D) on a disease endpoint (e.g. Multiple Sclerosis) using
the genes predictive of the biomarker as instrumental variables. A single dataset
does not usually contain information on the outcome, biomarker and genes and even
when it does the sample size is usually too low to yield precise inferences. Typically
one learns about the instrument-biomarker association from one data source and
instrument-gene association from another data source and these data sources are
married to estimate the causal effect of interest (Mokry and others , 2015; Burgess
and others , 2015). The environmental epidemiology literature also contain examples
where interest focuses on the association between an environmental exposure and
1
CHAPTER 1. INTRODUCTION
health outcomes. Typically, the exposure and health information are obtained from
distinct data sources; confounding factors may even be obtained from a third data
source. For example, Dominici and others (2006) studied the association between fine
particulate air pollution and hospital admission for cardiovascular and respiratory
diseases. Health information was obtained from billing claims of Medicare enrollees,
pollution data were obtained from EPA’s Aerometric Information Retrieval Service
and weather information (confounders) were obtained from the National Climatic
Data Center on the Earth-Info CD database. Social scientists also use multiple data
sources in their research. For example, Corvalan and others (2015) discusses how to
construct bounds on the causal effect of a change in a Chilean electoral law on voter
turnout using two separate data sources: aggregate level data of voter counts and
individual level demographic data.
This dissertation is devoted to the development of statistical methods to address
three important scientific problems. The methods involve combining information from
multiple data sources to address the scientific questions of interest. The following
three sections provide a gentle introduction to these problems.
2
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1.1 Enhancing Genetic Case-Control Stud-
ies Using Sample Surveys
In a typical case-control study, individuals are ascertained on the basis of their
disease status, i.e. whether they are a case or a control. The study design is ret-
rospective in the sense that exposure information is collected retrospectively. This
design is useful for characterizing the association of an exposure of interest and the
case-control status. In a genetic case-control study, the exposure of interest is usually
a genetic variant. The disease status that determines whether an individual is a case
or a control is often called a primary phenotype. In these studies, it is common of in-
vestigators to collect a battery of additional health outcomes referred to as secondary
phenotypes. An investigator may often be interested in exploring the relationship
between a genetic variant of interest and a secondary phenotype. For example, one
may want to learn about the relationship between a gene of interest and obesity from
an asthma case-control study that also collects obesity information for each individ-
ual. Since case-control data are not a random sample from the target population, the
observed association between a genetic risk factor and a secondary phenotype may be
biased. In order to correct for this bias it is necessary to utilize external information
or assumptions. In contrast to the case-control study design, a sample survey pro-
vides representative information on the target population of interest. While existing
methods make additional assumptions which may not be plausible in a given scien-
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tific setting, we propose an inferential framework that combines information from a
case-control study and a sample survey from the target population to learn about the
association between a secondary phenotype and a genetic risk factor. In particular,
the sample survey helps us obtain point estimates and uncertainty of the conditional
(on covariates) prevalence of disease that determines the case-control status. We can
learn about the conditional distribution of the secondary phenotype and genetic risk
factor given the primary phenotype and covariates from the case-control study. Using
both data sources, the conditional distribution of the secondary phenotype and the
gene given covariates becomes estimable.
By way of illustration, we study the relationship between a candidate gene (i.e.,
IKZF3-ZPBP2-GSDMB-ORMDL3 locus on chromosome 17q21) and obesity and how
this relationship differs by ethnicity (i.e., Puerto Ricans vs Mexicans). We use data
from the GALA (Genes-Environments and Admixture in Latino Americans) II asthma
case-control study and the NHIS (National Health Interview Survey). Our results
show that a naive analysis using the case-control data alone does not indicate a
gene-obesity association, while the combined analysis indicates a significant reces-
sive association. Moreover, there is no statistically significant evidence in favor of a
differential association across ethnicities.
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1.2 Causal Effect Among The Exposed:
Multiple Data Sources and Censored
Outcomes
We develop an inferential framework for estimating the causal effect among “ex-
posed” subjects on a time-to-event outcome, based on multiple data sources and
censored outcome information. Our major contribution is to conceptualize a hypo-
thetical point exposure study where subjects are enrolled and allowed to select their
own exposure. Using information from two data sources (one from exposed subjects
and one from non-exposed subjects with multiple examination times), we describe a
process of manufacturing a dataset that closely mimics this hypothetical study. The
identification of the causal effect relies on a no unmeasured confounding assumption
based on covariates available at exposure selection and a non-informative censoring
assumption. Estimation proceeds by fitting separate proportional hazards regression
models for exposed and non-exposed subjects using the manufactured dataset and
using G-computation to estimate, for exposed subjects, the distributions of time-
to-event under exposure and non-exposure. Using these estimated distributions, we
compute a parsimonious measure of the causal effect of interest.
We illustrate our methodology by addressing the question of whether kidney
donors are putting themselves at increased risk of adverse health consequences. We
5
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use information available on live kidney donors derived from hospital records at the
Johns Hopkins Hospital and follow-up interviews and healthy non-donors from two
prospective cohort studies (i.e., Atherosclerosis Risk in Communities (ARIC) and
Coronary Artery Risk Development in Young Adults (CARDIA) studies). We con-
sider two separate endpoints: hypertension-free survival and diabetes-free survival.
Our analysis does not provide any significant evidence that kidney donors are putting
themselves at an increased risk for these diseases. We also perform a realistic simu-
lation study to evaluate the performance of our proposed methodology.
1.3 Testing Equality of Curves After Co-
variate Adjustment
We develop simple methodological approaches for global and local tests of the
difference between the mean of treatment and control groups when the measured
outcome is a function. Our approach utilizes information from two data sources: one
coming from subjects in the treatment group and the other coming from the subjects
in the control group. The added complexity is that for every subject we have repeated
samples for the same curve and additional covariates of interest. A key feature of our
proposed methodology is that we are working with covariate adjusted curves which
is of critical importance in many applications where the distribution of the covariates
differ between groups. We propose a permutation based approach to test for equality
6
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of the averages of two functional processes after covariate adjustment. The within
group averages are estimated by modeling the relationship of the functional outcome
on the covariate using functional regression methods and then averaging with respect
to the covariate distribution in each group. The test statistic is the L2 area under
the squared difference curve. We also test for the localized differences between the
two average curves using a nonparametric bootstrap of subjects to obtain the 95%
pointwise and joint confidence intervals for the difference (Crainiceanu and others ,
2012).
We illustrate our method by studying the differences in time varying oxygen con-
sumption between Interleukin 10tm1Cgn (IL10tm) mice and wildtype mice after ad-
justing for body composition measures. While the body weight normalized oxygen
consumption is significantly altered in the 10tm1Cgn (IL10tm) mice compared to the
wildtype mice; the difference is not significant after adjusting for the ratio of fat and
lean mass measured at baseline. This is true for both the global differences and the
localized differences. Extensive simulation studies illustrate that the proposed tests




1.4 Overview of Dissertation
The dissertation is organized as follows. Chapters 2-4 discuss the details of the
projects described in Sections 1.1 - 1.3 above. In each chapter, we present (i) an
overview of the scientific problem, the shortcomings of the existing statistical method-
ology to address that problem and the relevance of our contribution; (ii) a description
of the theoretical details of the development of our statistical methods; (iii) an ex-
planation of the scientific findings; and (iv) a general discussion on the scope and
limitations of the method and its applicability to problems of similar nature. Chap-




Studies Using Sample Surveys
2.1 Introduction
Consider an unmatched case-control study in which diseased (cases) and non-
diseased (controls) individuals are each randomly sampled from a target population.
The disease of interest is considered the primary phenotype. Further, suppose the
main purpose of the study is to discover whether there is an association between
genetic factors and the primary phenotype. Towards this end, genetic information
is collected on each participant. Investigators often collect a battery of additional
clinically relevant phenotypes, referred to as secondary phenotypes. Such data are
often used to study genetic associations with secondary phenotypes.
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While disease-genotype associations (on an odds ratio scale) can be estimated
from case-control data (Prentice and Pyke, 1979), estimating the association between
a secondary phenotype and a genotype can only be done with additional information
or assumptions. In fact, nominal measures of association between the secondary
phenotype and genotypes can be biased (Lee and others , 1997). One may observe an
association between the secondary phenotype and the genotype in the case-control
sample, even if none exists in the population. On the other hand, one may observe
no association in the case-control sample, even if one exists in the population.
This issue has received attention in the literature, and several solutions have been
proposed. Nagelkerke and others (1995) and Kraft (2007) assume that either (a)
disease status is conditionally independent of the genotype given the secondary phe-
notype or (b) disease status is conditionally independent of the secondary phenotype
given the genotype. Unfortunately, these assumptions may not hold in the popula-
tion of interest. A number of methods are available when the sampling fractions for
cases and controls are known (Lee and others , 1997; Reilly and others , 2005; Jiang
and others , 2006; Richardson and others , 2007; Monsees and others , 2009; Tchet-
gen, 2014). Wang and Shete (2011), Chen and others (2013), He and others (2011),
Ghosh and others (2013) and Wei and others (2013) assume the disease prevalence is
known. One needs to be careful when assuming the prevalence is known. Specifically,
the prevalence needs to be computed from a population where the conditional distri-
bution of key risk factors given primary phenotype matches that in the case-control
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study. These methods also neglect the uncertainty in knowledge of prevalence. Li and
others (2010) and Wei and others (2013) considered the case where the disease is rare.
Unless the disease is rare, the likelihood-based approach of Lin and Zeng (2009) may
be unstable without additional information about prevalence. In short, unless the
disease is rare, current methods for analyzing secondary phenotype associations use
assumptions that may be false (e.g., conditional independence) or known imprecisely
(e.g., prevalence).
We address the problem by obtaining external information from a sample survey
of the target population of interest that also measures the primary phenotype. Our
inferential framework uses the point estimate and uncertainty of the disease prevalence
conditional on covariates from the sample survey. To illustrate our approach, we study
the relationship between a candidate gene (associated with asthma) and obesity, and
how this relationship differs by ethnicity. We use data from the Genes-Environments
& Admixture in Latino Asthmatics (GALA) II study, an asthma case-control study
in Latino American children, and the National Health Interview Survey (NHIS) 2010,
a national sample survey of households. The GALA II study provides information
about the conditional distribution of the genotype, obesity, and key confounders
given asthma status and ethnicity; the NHIS study provides information about the
probability of asthma given ethnicity and the key confounders. Information from
these two distinct data sources are combined to estimate standardized associations
between the gene and obesity within ethnicity strata; these are then compared across
11
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ethnicities.
2.2 Motivating Example and Data Sources
The GALA II study is the largest pediatric asthma genetic study in US Latinos.
The study enrolled approximately equal numbers of cases (children aged 8-21 years
with asthma) and controls from five urban cities in the US and Puerto Rico. The
two predominant ethnicities of US Latinos are Mexican (63%) and Puerto Rican
(9%), who have very different rates of asthma. Approximately 30% of Puerto Rican
and 12% of Mexican youth suffer from asthma (http://www.cdc.gov/asthma/nhis/
2011/table2-1.htm). These prevalences represent two extremes among major ethnic
groups in the US. The causes underlying this disparity have puzzled researchers; it is
likely that social, cultural, and genetic factors contribute (Thakur and others , 2013).
Given the disparity in asthma prevalence between Latino subgroups, GALA II was
designed to study environmental and genetic factors affecting asthma in Latinos. In
addition to genetic data, GALA II collected information on obesity, age, gender and
ethnicity.
Another growing public health concern in pediatric populations is obesity whose
incidence has been increasing steadily. Many studies have indicated that obesity in-
creases the prevalence and incidence of asthma. Both diseases may arise in childhood,
and there are reasons to believe that there are shared etiologic factors that contribute
12
CHAPTER 2. ENHANCING GENETIC CASE-CONTROL STUDIES USING
SAMPLE SURVEYS
to both diseases (e.g., inflammation). It is also possible that one condition may ad-
versely affect the other (e.g., lung volume is reduced by obesity which leads to reduced
lung function). It is, therefore, of interest to examine to what extent common genetic
factors contribute to both diseases.
The most prominent genetic region that has been repeatedly implicated in asthma
is the IKZF3-ZPBP2-GSDMB-ORMDL3 locus on chromosome 17q21. The associa-
tion has been replicated in diverse populations from Europe, North America and Asia.
Due to strong linkage disequilibrium across the 17q21 locus, separating the contribu-
tions of the genes underlying this locus has been challenging. Nonetheless, because
of the co-occurrence of asthma and obesity, this locus is a prime candidate for being
associated with obesity susceptibility as well.
We focus on one SNP, rs12232497, which has the highest odds ratio for asthma sus-
ceptibility in the GALA II population. We examine its association with obesity, being
open to the possibility that the association may differ in different ethnic groups (i.e.,
Mexicans and Puerto Ricans). Our goal is to estimate the association between this
SNP and obesity, separately for Mexicans and Puerto Ricans, and evaluate whether
there is a differential association.
To realize this goal, we obtain external information from the NHIS-2010 (NCHS,
2011). The NHIS is conducted annually by the National Center for Health Statistics
and Centers for Disease Control and Prevention. The NHIS administers face-to-face
interviews in a nationally representative sample of households. Within each sampled
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household with children under the age of 18 years, a detailed survey was conducted on
one randomly selected child. A knowledgable adult provided proxy responses for the
selected child. Information collected included health measures such as asthma and
obesity and demographic factors such as age, gender and ethnicity. Survey weights
are included in the NHIS data files to allow for population-level inference.
2.3 Methods
Let A denote asthma status (primary phenotype of interest), for which the case-
control sample was assembled. We wish to study the association between genotype (G;
coded as 0, 1, 2 based on the number of copies of the minor allele) and the secondary
phenotype, obesity (O) within ethnicity strata (E). It is important to control for
demographic factors (X), such as age and gender. If the association between G and
O is modified by X and the distribution of X is different across E, then we may
see a differential association between G and O across strata that results solely from
differences in the distribution of X. To address this problem, we seek to estimate the
association between the genotype and obesity in a “world” in which the distribution
of age and gender is common across strata and is fixed. This is akin to the idea of
standardization in epidemiology. We assume the reference population to have uniform
age distribution between ages 8-18 years and a 1:1 gender ratio. This is a reasonable
approximation to a stable population with low levels of child mortality.
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Our goal is the measure the ethnicity-specific association between O and G. In
particular, we want the ethnicity-specific joint distribution of O and G, which can be
expressed as:
Pe[O = o,G = g] =
∫
Pe[O = o,G = g|X = x]dF (x)
where Pe denotes a probability distribution conditional on E = e and F (x) denotes
the distribution of demographic factors (age and gender) in the reference population.
Note that, Pe[O = o,G = g|X = x] is not estimable from the case-control data
alone or the survey data alone. This is because the survey does not contain genotype
information, and the case-control study only allows us to learn about ethnicity-specific
joint distributions conditional on asthma and covariates i.e., Pe[O = o,G = g|A =
a,X = x] for a = 0, 1. However, we can express Pe[O = o,G = g|X = x] as:








Pe[O = o|G = g, A = a,X = x]Pe[G = g|A = a,X = x]︸ ︷︷ ︸
Estimable from Case-Control Study
Pe[A = a|X = x]︸ ︷︷ ︸
Estimable from Survey
Thus, by using both data sources, Pe[O = o,G = g|X = x] becomes estimable.
For inference, we posit parametric models for Pe[O = o|G = g, A = a,X = x],
Pe[G = g|A = a,X = x] and Pe[A = a|X = x]. Specifically, we posit a logistic
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regression model for obesity given genotype, asthma and covariates:
logit{Pe[O = 1|G = g, A = a,X = x]} = h(e, g, a, x; γ); (2.1)
a proportional odds model for genotype given asthma and covariates:
logit{Pe[G ≤ g|A = a,X = x]} = β0,g + β1,e + β2,ea g = 0, 1 (2.2)
and a logistic regression model for asthma given demographic factors:
logit{Pe[A = 1|X = x]} = l(e, x; δ) (2.3)
where h(e, g, a, x; γ) is a specified function of e, g, a, x and parameter vector γ, there
exists one level of e for which β1,e = 0 and l(e, x; δ) is a specified function of e,
x and parameter vector δ. In model 2.2, we assume that genotype is independent
of demographic factors (X) given asthma status; the data do not provide evidence
against this assumption. In our analysis, X is age and gender, and we set, after
model fitting,
h(e, g, a, x; γ) = γ0,e + γ1a+ γ2I(g = 1) + γ3I(g = 2) + γ4age + γ5gender +
γ6I(g = 1) · a+ γ7I(g = 2) · a+ γ8age · a+ γ9gender · a
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l(e, x; δ) = δ0,e + δ2gender + δ3ns(age; 5, 11) + δ4gender · ns(age; 5, 11)
where ns(age; 5, 11) is a B-spline basis for a natural cubic spline with knots at ages
5 years and 11 years. The spline functions were used to model the non-linear depen-
dence of prevalence of asthma with age. The parameters from models 2.1, 2.2 and
2.3 can be estimated using the R functions glm, polr and survglm, respectively. In
estimating the parameters of model 2.3, survey weights (obtained from the sample
survey) are utilized. The R functions output parameter estimates γ̂, β̂ and δ̂ and
associated estimated variance-covariance matrices denoted by Σ̂γ̂, Σ̂β̂, and Σ̂δ̂, re-
spectively. The parameter estimators from these models are asymptotically normal
and asymptotically uncorrelated.
We estimate Pe[O = o,G = g] by Monte Carlo integration using





P̂e[O = o,G = g|X = xm]
where M is a large number; x1, . . . , xM are independent draws from distribution F (x),




P̂e[O = o|G = g, A = a,X = x]P̂e[G = g|A = a,X = x]P̂e[A = a|X = x]
P̂e[O = o|G = g, A = a,X = x] =
exp(o× h(e, g, a, x; γ̂))
1 + exp(h(e, g, a, x; γ̂))
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P̂e[A = a|X = x] =
exp(a× l(e, x; δ̂))
1 + exp(l(e, x; δ̂))
Given the categorical nature of the genotype and phenotype data, there are differ-
ent ways of expressing their association. One way is to consider ethnicity-specific odds
ratios. The three odds ratios we consider are the recessive, dominance and additive
odds ratios. The recessive and dominance odds ratios are estimated by
̂Recessive Odds Ratio =
P̂e[O = 1, G = 2]P̂e[O = 0, G = 0, 1]
P̂e[O = 1, G = 0, 1]P̂e[O = 0, G = 2]
̂Dominance Odds Ratio =
P̂e[O = 1, G = 1, 2]P̂e[O = 0, G = 0]
P̂e[O = 1, G = 0]P̂e[O = 0, G = 1, 2]
We can also estimate the ethnicity-specific additive odds ratio (exp(ηe)) from the
following model:
logitPe[O = 1|G = g] = η0,e + ηeg
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where
P̂e[G = g] =
1∑
o=0
P̂e[O = o,G = g]
P̂e[O = 1|G = g] =
P̂e[O = 1, G = g]
P̂e[G = g]
This latter estimation procedure is called weighted minimum distance estimation
(Klugman and Parsa, 1994).
Since these odds ratio estimators are smooth functions of γ̂, β̂ and δ̂, they will
also be asymptotically normal. In the Appendix (2.6.1), we present estimates of the
standard errors of these estimators. In our analysis, we construct normality-based
confidence intervals on the log scale and then exponentiate.
2.4 Results
GALA II study
There were 3757 individuals in the GALA II dataset; 1786, 1245, 105 and 621 were
classified as Puerto Rican, Mexican, Mixed Latino and Other Latino, respectively.
The age range was 8-21 years. The SNP of interest, rs12232497, has major allele T
and minor allele C. Among Puerto Ricans, 9 had missing information on the SNP of
interest and 618 had missing information on body mass index (BMI), derived from
height and weight and used to determine obesity status. Among Mexicans, these
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numbers were 1 and 171, respectively. There was no missing SNP information among
Mixed and Other Latinos. BMI was missing on 9 and 178 among Mixed Latinos and
Other Latinos, respectively. The majority of the missing obesity information was
among controls. This is because controls were not originally scheduled to be given
spirometry tests and these tests require the collection of information on height and
weight. There was differential missingness of BMI by ethnicity. This was due to the
multi-site nature of the study. Each site had different recruitment goals and ethnic
profiles. When the policy to collect height and weight among controls was instituted,
sites who recruited more Puerto Ricans and Other Latinos were further along in their
recruitment goals than sites who recruited more Mexicans and Mixed Latinos. Our
analysis uses data on patients who have completely recorded SNP and BMI, which
is 1163 Puerto Ricans (886 cases, 277 controls), 1073 Mexicans (585 cases and 488
controls), 96 Mixed Latinos (61 cases, 35 controls) and 443 Other Latinos (337 cases,
106 controls). The validity of our analysis hinges on the additional, untestable, albeit
plausible assumption, that missingness of BMI and SNP data is unrelated to obesity
status and the gene given case/control status, ethnicity, age and gender.
Table 2.1 displays various measures of the adjusted (for age and gender) associ-
ation between asthma and the genotype based on the case-control data for Puerto
Ricans and Mexicans. These results suggest that the minor allele C is associated
with a decreased risk of asthma in Puerto Ricans (additive odds ratio = 0.66 [95%
CI: 0.54, 0.82]) and Mexicans (additive odds ratio = 0.70 [95% CI: 0.57, 0.85]). The
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Table 2.1: Measures of marginal association between asthma and genotype adjusted
for age and gender based on the GALA II study.
Measure of Puerto Ricans Mexicans Interaction
G-A association Estimate (95% CI) Estimate (95% CI) Estimate (95% CI)
Dominance odds ratio 0.60 (0.45,0.79) 0.68 (0.53,0.87) 0.88 (0.61,1.28)
Recessive odds ratio 0.59 (0.37,0.95) 0.52 (0.33,0.82) 1.12 (0.59,2.16)
Additive odds ratio 0.66 (0.54,0.82) 0.70 (0.57,0.85) 0.94 (0.71,1.26)
association is not significantly different between these ethnic subgroups.
Tables 2.2 and 2.3 present the observed frequency distribution of obesity and
genotype from the case-control data for Puerto Ricans and Mexicans, respectively.
Table 2.4 presents adjusted (for age, gender and asthma status) measures of associ-
ation between obesity and the genotype for Puerto Ricans and Mexicans, based on
the case-control data. Based on this naive analysis, there is no significant association
between obesity and genotype (all confidence intervals cover 1).
Tables 2.5 and 2.6 present the results of fitting Models 2.1 and 2.2 based on the
case-control data.
NHIS study
The NHIS dataset contains information on 11,277 children in the age range 0-17
years; 167, 311, 2285, 102, 111, 489, 13, 40, 7759 were classified as Multiple Hispanic,
Puerto Rican, Mexican, Cuban/Cuban American, Dominican (Republic), Central
or South American, Other Latin American (type not specified), Other Spanish, Not
21
CHAPTER 2. ENHANCING GENETIC CASE-CONTROL STUDIES USING
SAMPLE SURVEYS
Table 2.2: Observed frequency distribution of obesity and genotype in Puerto Ricans




Non-obese Obese Total Non-obese Obese Total
0 325(36.68) 123(13.88) 448(50.56) 84(30.33) 23(8.30) 107(38.63)
1 264(29.80) 111(12.53) 375(42.33) 107(38.63) 33(11.91) 140(50.54)
2 42(4.74) 21(2.37) 63(7.11) 29(10.47) 1(0.36) 30(10.83)
Total 631(71.22) 255(28.78) 886(100) 220(79.43) 57(20.57) 277(100)
Table 2.3: Observed frequency distribution of obesity and genotype in Mexicans




Non-obese Obese Total Non-obese Obese Total
0 175(29.91) 139(23.76) 314(53.67) 163(33.40) 58(11.89) 221(45.29)
1 152(25.98) 84(14.36) 236(40.34) 136(27.87) 79(16.19) 215(44.06)
2 17(2.91) 18(3.08) 35(5.99) 39(7.99) 13(2.66) 52(10.65)
Total 344(58.80) 241(41.20) 585(100) 338(69.26) 150(30.74) 488(100)
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Table 2.4: Measures of marginal association between obesity and genotype in the
naive analysis adjusted for age, gender and asthma based on GALA II study.
Puerto Ricans Mexicans Interaction
Measure of
G-O association
Estimate (95% CI) Estimate (95% CI) Estimate (95% CI)
Dominance odds ratio 1.05 (0.81,1.37) 0.96 (0.75,1.23) 1.10 (0.76,1.57)
Recessive odds ratio 0.82 (0.49,1.33) 0.96 (0.60,1.50) 0.85 (0.43,1.66)
Additive odds ratio 0.99 (0.81,1.22) 0.97 (0.79,1.17) 1.03 (0.77,1.37)
Table 2.5: Results from obesity model (2.1) based on GALA II study.
Covariate Estimate Std. error Z-value P
Mexican -0.77 0.33 -2.31 0.021
Mixed Latino -0.84 0.40 -2.12 0.034
Other Latino -0.81 0.35 -2.33 0.020
Puerto Rican -1.35 0.34 -4.00 < 0.0001
Asthma 0.65 0.39 1.67 0.096
Gender -0.28 0.15 -1.81 0.070
Age 0.0037 0.022 0.17 0.86
One Copy 0.18 0.16 1.11 0.270
Two Copies -0.60 0.30 -2.00 0.045
Asthma*Gender 0.013 0.18 0.07 0.95
Asthma*Age -0.0072 0.027 -0.27 0.79
Asthma*One Copy -0.31 0.19 -1.65 0.099
Asthma*Two Copies 0.78 0.36 2.17 0.030
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Table 2.6: Results from genotype model (2.2) based on GALA II study (Mexican is
reference ethnicity).
Covariate Estimate Std. Error Z-value P
Zero Copies -0.22 0.09 -2.49 0.013
One Copy 2.27 0.10 21.64 < 0.0001
Mixed Latino 0.10 0.32 0.32 0.748
Other Latino 0.20 0.21 0.98 0.328
Puerto Rican 0.22 0.14 1.55 0.121
Asthma (Mexicans) -0.38 0.12 -3.19 0.001
Asthma (Mixed Latino) -0.55 0.40 1.37 0.172
Asthma (Other Latino) -0.63 0.22 2.92 0.004
Asthma(Puerto Ricans) -0.47 0.13 3.59 0.0003
Hispanic/Spanish origin respectively. 21 children have missing information on asthma
status; 3 of them were Mexican, 1 Central or South American and 17 were not of
Hispanic/Spanish origin. Of the 21 children with missing asthma status, 4 refused
response and 17 did not know their asthma status information. Estimation of Model
2.3 made use of data on 11,256 children (1569 with asthma and 9687 without asthma)
who have complete information on asthma status. Table 2.7 presents the results of
fitting Model 2.3 using the survey weights.
Figure 2.1 shows the variation of prevalence of asthma with age for different gen-
ders in Puerto Ricans and Mexicans as explained by Model 2.3. We observe a steep
increase in the prevalence of asthma with age in the range 0-7 years; Puerto Ricans
have a greater rate of this increase compared to Mexicans. The relationship gets flat-
ter for older males in both ethnic groups. The younger females have a lower prevalence
of asthma compared to younger males. After a steep increase in the age range 0-7
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Table 2.7: Results from asthma model (2.3) based on NHIS 2010.
Covariate Estimate Std. Error t-value P
Multiple Hispanic -2.9496 0.3408 -8.66 < 0.0001
Puerto Rican -1.9454 0.2495 -7.80 < 0.0001
Mexican -3.0946 0.2191 -14.12 < 0.0001
Cuban/Cuban American -2.9441 0.5053 -5.83 < 0.0001
Dominican (Republic) -2.6618 0.3690 -7.21 < 0.0001
Central or South American -3.1891 0.2527 -12.62 < 0.0001
Other Latin American, type not specified -3.9114 1.0683 -3.66 0.0003
Other Spanish -3.6461 0.6467 -5.64 < 0.0001
Not Hispanic/Spanish origin -2.8233 0.2053 -13.75 < 0.0001
Gender -0.4815 0.3197 -1.51 0.1332
ns(age; 5,11)1 0.9582 0.1895 5.06 < 0.0001
ns(age; 5,11)2 2.5305 0.4590 5.51 < 0.0001
ns(age; 5,11)3 0.5179 0.1399 3.70 0.0003
Gender × ns(age; 5,11)1 0.0926 0.2993 0.31 0.7572
Gender × ns(age; 5,11)3 0.3806 0.7110 0.54 0.5929
Gender × ns(age; 5,11)3 0.4418 0.1928 2.29 0.0227
Table 2.8: Measures of marginal association between obesity and genotype from the
combined analysis based on GALA II Study and NHIS 2010.
Puerto Ricans Mexicans Interaction
Measure of
G-O association
Estimate 95% CI Estimate 95% CI Estimate 95% CI
Dominance odds ratio 0.95 0.78, 1.17 1.01 0.79, 1.30 0.94 0.86, 1.03
Recessive odds ratio 0.65 0.44, 0.95 0.56 0.36, 0.89 1.15 0.94, 1.41
Additive odds ratio 0.90 0.78, 1.04 0.91 0.77, 1.09 0.98 0.92, 1.05
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Figure 2.1: Variation of asthma prevalence with age (in years), gender and ethnicity
as explained by Model (2.3). Note that we used B-spline basis for a natural cubic
spline to smooth over age.
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years, the prevalence of asthma for females keeps increasing but at a slower rate. In
the older age-groups, the differences in the prevalence of asthma between males and
females decreases. Thus, there is evidence of interaction between age and gender.
Combined analysis
In our combined analysis we worked with a reference population of size M = 2000.
Table 2.8 presents our results. The recessive odds ratio between obesity and genotype
is significantly less than 1 in both Puerto Ricans and Mexicans, i.e. the individuals
with 2 copies of the minor allele are at a lower risk of obesity compared to 0 or 1
copy.
Figure 2.2 shows the point estimates and 95% confidence intervals for log-odds
of Pe[O = 1|G = g] for g = 0, 1, 2 for both Puerto Ricans and Mexicans. The plots
show evidence in favor of a recessive inheritance model. For each ethnic group, the
points in Figure 2.2 are not on a straight line; a strong indication that the additivity
assumption may not hold. We computed point estimates and 95% confidence intervals
for τe = logit(Pe[O = 1|G = 2]) − 2logit(Pe[O = 1|G = 1]) + logit(Pe[O = 1|G = 0])
for both Puerto Ricans and Mexicans. When the additivity assumption holds τe = 0.
For Mexicans, the evidence against additivity assumption is statistically significant
[τ̂e = −0.73, 95% CI: −1.34,−0.13]; for Puerto Ricans it is of borderline significance
[τ̂e = −0.46, 95% CI: −0.98, 0.05].
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Figure 2.2: Variation of log-odds of obesity with genotype in Puerto Ricans and
Mexicans obtained from our methodology. We show the point estimates and 95%
confidence intervals (vertical bars) for the log-odds of obesity at the different levels
of the gene (i.e. logit(Pe[O = 1|G = g]) for g = 0, 1, 2) for both Puerto Ricans and
Mexicans.
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2.5 Discussion
The analysis of secondary phenotypes in genetic case-control studies are subject to
bias. We presented an approach to mitigate this bias by integrating information from
representative sample surveys. In the combined analysis we found that individuals
with 2 copies of the minor allele are at a lower risk of obesity compared to 0 or 1
copy. The naive analysis of the GALA II dataset that ignores the selective sampling of
cases and controls results in null findings. This illustrates the drawbacks of the naive
analysis of case-control data. Our statistical framework for estimating uncertainty
includes sampling uncertainty from both the sample survey and the case-control study.
More generally, our framework allows one to obtain population-level estimates of
genetic effects on clinical quantities (e.g., serum glucose level, concentration of a
metabolite etc) that would be hard to measure in a large scale sample survey.
The conditional independence assumptions of Nagelkerke and others (1995) and
Kraft (2007) do not hold in our case. In particular, there is statistical evidence that
asthma status is not conditionally independent of the genotype given obesity status
for Puerto Ricans (Cochran-Mantel-Haenszel P = 0.001) and Mexicans (Cochran-
Mantel-Haenszel P = 0.003); and asthma status is not conditionally independent of
obesity status given genotype for Puerto Ricans (Mantel-Haenszel P = 0.008) and
Mexicans (Mantel-Haenszel P = 0.0005).
In our setting, the sampling fractions of cases and controls are not known. Using
an approach that requires specification of the prevalence of asthma is difficult because
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it is essential that it be computed from a population where the conditional distribu-
tion of key risk factors given asthma status matches that in the case-control study.
Furthermore, it is important to reflect the uncertainty associated with the estimate of
prevalence. It is possible to show theoretically that when we do not control for demo-
graphic factors (e.g. age and gender) the 95% confidence intervals for P [O = o,G = g]
will be wider when prevalence of asthma is estimated with uncertainty from an ex-
ternal data source (e.g. sample survey) relative to when it is assumed known (details
in Appendix (2.6.2)). In our example this increase in width is small but consistent
with theory (data not shown).
Since asthma is a common disease, the rare disease assumption by Li and others
(2010) is not justified. The profile likelihood method of Lin and Zeng (2009) pro-
files out the distribution of the genetic risk factor when the disease is common and
prevalence of disease is unknown. We implemented their method for our case-control
dataset, but the model parameters (including the prevalence of asthma) are not iden-
tifiable in the sense that multiple maximizers of their profile likelihood were found.
Our proposed methodology does not make the above assumptions and also provides
a framework for control of key demographic factors.
In our framework, the analyst has to choose the structure of the reference popu-
lation. We chose a population with equal sex ratios and a uniform age distribution.
In general, there may be disagreement on the appropriate reference population, but
sensitivity to such disagreement is easily examined by considering a range of reference
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population characteristics.
The use of our method assumes the existence of a sample survey where the primary
phenotype of the case-control study is also measured. There may be differences in
how the phenotype is measured in the two data sources. This can lead to additional
biases. For example, in GALA II, measurement of asthma was based upon physi-
cian diagnosis. In contrast, the NHIS survey used self-report from an adult in the
household about whether the child had a physician diagnosis of asthma. Moreover,
in the case-control study, the individuals within asthma-age-gender-ethnicity strata
may not be representative. This can also lead to some bias.
In general, the covariates such as age and gender should be independent of geno-
type in the population. Adding this constraint can lead to efficiency improvement.
Similarly, it may be reasonable to assume the genotypes are in Hardy-Weinberg equi-
librium in the population. This constraint could also lead to improvements in effi-
ciency. These arguments for improving efficiency rely on the modeling assumptions
being correctly specified and if not, they might introduce bias. Thus the analyst has
to make careful choices in trading off bias and variance.
Genetic case-control studies typically characterize subjects in great clinical detail,
making it difficult to conduct on a large scale. Moreover, these studies are biased by
design. Sample surveys are designed to be representative, but do not allow detailed
clinical characterization. Our method provides a statistical framework to leverage
the strengths of sample surveys with case-control studies to provide unbiased genetic
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association estimates of clinical phenotypes that are hard to measure in large scale
surveys.
2.6 Appendix
2.6.1 Computation of standard errors
In Section 2.3 we saw that for a particular ethnicity stratum e, the 6 × 1 vec-
tor of probabilities {Pe[O = o,G = g] : o = 0, 1; g = 0, 1, 2} can be expressed as
a 6-variate smooth function f(γ∗, β∗, δ∗), where γ∗, β∗, δ∗ are the true values of the
parameters γ, β, δ respectively. The parameter estimates γ̂, β̂ and δ̂ and their esti-
mated variance-covariance matrices Σ̂γ̂, Σ̂β̂ and Σ̂δ̂ are obtained by fitting the models
2.1, 2.2 and 2.3 in Section 2.3. The parameter estimates are asymptotically normal
and asymptotically uncorrelated. A simple application of Multivariate Delta The-
orem shows that the distribution of the centered and scaled vector of probabilities
P̂e[O = o,G = g] is asymptotically normal with variance covariance matrix given by
DΣD′ where D is the appropriate matrix of derivatives and Σ is the block diagonal
matrix with the blocks given by Σγ̂, Σβ̂ and Σδ̂ respectively. The ethnicity specific
dominance odds ratio and recessive odds ratio defined in Section 2.3 are smooth func-
tions of {Pe[O = o,G = g] : o = 0, 1; g = 0, 1, 2} and hence another application of
Delta Theorem gives us the asymptotic distribution of the point estimates of these
association measures.
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Note that the ethnicity specific additive odds ratio (exp(ηe)) is obtained from the
following model:
logitPe[O = 1|G = g] = η0,e + ηeg











P̂e[G = g] =
1∑
o=0
P̂e[O = o,G = g]
P̂e[O = 1|G = g] =
P̂e[O = 1, G = g]
P̂e[G = g]
This latter estimation procedure is called weighted minimum distance estimation.
In what follows we discuss how to compute standard errors of the ethnicity specific
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Denote the solution by (η̂0,e,η̂e). A first order Taylor series expansion around (η0,e,ηe)







































) η̂0,e − η0,e
η̂e − ηe
 (2.6)
where ||(η(1)0,e , η
(1)








































) η̂0,e − η0,e
η̂e − ηe
 (2.7)
where ||(η(2)0,e , η
(2)
e )−(η0,e, ηe)|| < ||(η̂0,e, η̂e)−(η0,e, ηe)||. The expressions for the double
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Solving 2.6 and 2.7, we have:
 η̂0,e − η0,e
η̂e − ηe
 = −J−1b (2.8)
From the asympotic distribution of {P̂e[O = o,G = g] : o = 0, 1; g = 0, 1, 2} we
derive the asymptotic distributiom of {P̂e[G = g], P̂e[O = 1|G = g] : g = 0, 1, 2}
by an application of Multivariate Delta Theorem. Similarly from the asymptotic
distribution of {P̂e[G = g], P̂e[O = 1|G = g] : g = 0, 1, 2}, we compute the asymptotic
distribution of b. Note that J−1 will converge in probability to the inverse of a
matrix whose entries are the double partial derivatives of L evaluated at the true
values of the arguments. An application of Slutsky’s Theorem in 2.8 gives us the
asymptotic distribution of LHS of 2.8 (appropriately scaled) and hence the asymptotic
distribution of the additive odds ratio.
2.6.2 Related Asymptotics
Focus on a particular ethnicity stratum E = e. Consider the case when we do
not control for demographic factors (e.g., age and gender). We want to compare
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the asymptotic standard errors of {P̂e[O = o,G = g] : o = 0, 1; g = 0, 1, 2} when
Pe[A = 1] is known versus when it is estimated with uncertainty from some external
data source. First consider the case when it is estimated from an external data source.
Note that:
Pe[O = o,G = g] =
1∑
a=0
Pe[O = o,G = g|A = a]Pe[A = a]
Note that {P̂e[O = o,G = g|A = 1] : o = 0, 1; g = 0, 1, 2}, {P̂e[O = o,G = g|A =
0] : o = 0, 1; g = 0, 1, 2} and P̂e[A = 1] are asymptotically uncorrelated; denote
the asymptotic variances by ΣA=1, ΣA=0 and σ
2
A respectively. The combined vari-
ance covariance matrix Σ is block diagonal with ΣA=1, ΣA=0 and σ
2
A as the diagonal
blocks. By Multivariate Delta Theorem, the asymptotic variance-covariance matrix




T , where v is the vector of the differences {P [O = o,G = g|A =
1]−P [O = o,G = g|A = 0] : o = 0, 1; g = 0, 1, 2}. Note that σ2AvvT is a non-negative
definite matrix. When the prevalence of asthma is assumed known, the last term in
the variance expression is not there. This implies, the difference in the variance of
{P̂e[O = o,G = g] : o = 0, 1; g = 0, 1, 2} when Pe[A = 1] is estimated with uncer-
tainty versus when it is treated as a known constant is non-negative definite. Hence
we have wider 95% confidence intervals for {Pe[O = o,G = g] : o = 0, 1; g = 0, 1, 2}
when Pe[A = 1] is estimated versus when it is known.
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Causal Effect Among The
Exposed: Multiple Data Sources
and Censored Outcomes
3.1 Introduction
Consider a setting where a group of autonomous individuals choose to expose
themselves to an intervention with potentially adverse consequences. To understand
the risk associated with their choice, researchers may be interested in contrasting the
distribution of their outcomes under exposure to the intervention to the distribution
of their corresponding outcomes had they, contrary to fact, not exposed themselves to
the intervention. That is, researchers would like to draw inference about the causal
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effect among the exposed. Geneletti and Dawid (2011) refer to this estimand as
the “effect of treatment on the treated”. Our interest in this estimand is motivated
by the question of whether individuals who choose to donate kidneys are putting
themselves at increased risk for adverse health outcomes such as diabetes and hyper-
tension. Specifically, we would like to learn whether kidney donation accelerates the
development of these outcomes.
Since it is not possible to observe the counterfactual outcomes among the ex-
posed individuals, it is necessary to (1) utilize data from non-exposed individuals
and (2) posit untestable assumptions in order to learn about the causal effect of
interest. In addressing the kidney donation question, we use information available
on live kidney donors derived from hospital records and follow-up interviews and on
healthy non-donors from two prospective cohort studies. We consider the endpoints
of hypertension-free and diabetes-free survival. Our analysis is complicated by the
fact that, in the data sources, the endpoint is censored in the broadest sense (i.e., a
combination of interval-censored, right censored and exact observations).
In Section 3.2, we develop a method for drawing inference about the causal effect
among the exposed based on censored survival outcome data obtained for exposed and
non-exposed individuals from different data sources. Section 3.3 applies this method
to address our motivating question. Section 3.4 presents a detailed simulation study
to evaluate the performance of our methodology. The final section 3.5 is devoted to
a discussion.
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3.2 Methods
Consider a hypothetical study design in which eligible patients are enrolled and
given the option to select “exposure” (e.g., kidney donation) or “non-exposure”. Fur-
ther, assume that the mechanism of exposure selection only depends on observed
covariates at the time of enrollment. The patients are then followed from enroll-
ment to the minimum of death or some disease of interest (e.g., hypertension or
diabetes). Let Z denote the indicator that the patient opts for “exposure” and W
denote the covariates measured at enrollment. Let T1 and T0 denote the time from
enrollment to death or disease (whichever occurs earlier) for a patient under “expo-
sure” and “non-exposure” respectively. Our goal is to learn about the causal effect
among exposed subjects. That is, we want to compare S1(t)
def
= P [T1 > t|Z = 1]
and S0(t)
def
= P [T0 > t|Z = 1], for all t. The study design is assumed to provide
information about the joint distribution of (W,Z, T ), where T = ZT1 + (1− Z)T0.
3.2.1 Identification of Causal Parameters
In this hypothetical study design we assume
Z ⊥ (T1, T0)|W (3.1)
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i.e. exposure selection depends only on the measured covariates at enrollment. Under
Assumption (3.1),





P [T > t|W = w,Z = 0]dF (w|Z = 1) (3.3)
Under Assumption (3.1), Equations (3.2) and (3.3) provide identification formulae
for S1(t) and S0(t). From these equations, it follows that in order to estimate S1(t)
and S0(t), we need to be able to estimate (1) the distribution of T given Z = 1, (2)
the distribution of W given Z = 1, and (3) the distribution of T given W and Z = 0.
3.2.2 Manufactured Dataset
Unfortunately, in our setting, it is not possible to conduct the hypothetical study.
Rather, we have access to multiple data sources, which we will use to construct a
dataset D∗ that mimics what might arise from our hypothetical study. To illustrate
this construction we will use minimum of hypertension or death as the event of inter-
est. Assume, for the moment, that our data sources provide access to exact times of
the event of interest.
Our first data source, D1, includes patients who donated kidneys. For these
patients, the time of enrollment is the time of kidney donation. Figure 3.1(a) displays
three patients, numbered 1, 2, 3 in green, from this data source. Patient 1 donates a
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kidney in 1975, develops hypertension in 1990 (black cross) and dies in 2000 (black
asterisk). His time to event is time since kidney donation to the development of
hypertenstion (i.e., 15 years). Patient 2 donates a kidney in 1990 and dies without
developing hypertension in 2010. His time to event is time since kidney donation to
death (i.e., 20 years). Patient 3 donates a kidney in 1980 and dies without developing
hypertension in 1995. His time to event is time since kidney donation to death (i.e.,
15 years). In contrast to the next data source, all of these patients have a single
enrollment visit, denoted by v1 in the figure.
Our second data source, D0, includes patients who have not donated kidneys.
Each patient has possibly multiple examination times (i.e., multiple visits v1, v2, . . .
marked with blue dots). Figure 3.1(c) shows three patients, numbered 1, 2, 3 in blue,
from this data source. Patient 1 enters the study in 1985 (marked with label v1), has
a follow-up examination in 1988 (marked with label v2) and eventually dies without
developing hypertension in 1998. Patient 2 enters the study in 1988 and has three
follow-up examinations in 1991, 1995 and 2009. He develops hypertension in 2005
(between the third and fourth follow-up examinations) and eventually dies in 2012.
Patient 3 enters the study in 1991, develops hypertension in 2001 and dies in 2005.
Figure 3.1(b) is the manufactured dataset D∗ that represents (on a study time
scale) our hypothetical study described above. This dataset is created by patching
together D1 and D0 as follows. Each patient in D1 contributes one enrollment to the
hypothetical dataset, i.e. patients 1, 2 and 3 in Figure 3.1(a) contributes the first
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three enrollments in Figure 3.1(b). Each patient in the data source D0 (cf Figure
3.1(c)) contributes an “enrollment” at each examination time that occurs before the
event the of interest. That is, time of each “enrollment” is considered as a potential
time at which the patient could have been eligible to donate a kidney. Patient 1
contributes two “enrollments” to the hypothetical dataset (i.e. the fourth and fifth
“enrollments” in Figure 3.1(b)). Patient 2 contributes three “enrollments” to the
hypothetical dataset (i.e. sixth, seventh and eighth “enrollments” in Figure 3.1(b)).
The fourth visit of Patient 2 is not considered an “enrollment” since it occurs after
the event. Patient 3 contributes the last “enrollment” in Figure 3.1(b). Note that
in both the data sources we have measured covariates W (age, gender, race, BMI)
on the patients at each “enrollment”. The idea of multiple enrollments for individual
patients was employed by Hernán and others (2005) to estimate the causal effect of
a time varying exposure on a possibly right censored survival outcome.
If we can think of this manufactured dataset as representing our hypothetical
study design, then we are able to identify the causal parameters via equations (3.2)
and (3.3). This includes making the working assumption that all entries into the
manufactured dataset are independent. We relax this assumption when characterizing
the uncertainty of our estimation procedure.
In reality, we do not observe exact times to event in D1 and D0. Instead what we
observe is censored survival data, which is a combination of interval-censored, right
censored and exact observations. Figure 3.2 illustrates different censoring scenarios.
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Figure 3.1: Illustration of the process of manufacturing a dataset having the same
features as the hypothetical study by patching together two data sources: D1 from
the patients (numbered in green color) who have donated kidneys; and D0 from the
patients (numbered in blue color) who are “eligible” donors but have not donated
kidneys. (a) schematic representation of the patients in D1 with solid green dots
denoting “enrollment” (i.e., kidney donation) and green line denoting time from en-
rollment to either hypertension (black cross) or death (black asterisk); (b) schematic
representation of the manufactured hypothetical dataset, (c) schematic representa-
tion of the patients in D0 with solid blue dots denoting multiple “enrollments” and
blue line denoting time from an enrollment to either hypertension or death.
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Figure 3.2: Illustration of the process of manufacturing a dataset having the same
features as the hypothetical study by patching together two data sources: D1 from
the patients (numbered in green color) who have donated kidneys; and D0 from the
patients (numbered in blue color) who are “eligible” donors but have not donated
kidneys. The outcome could be censored (combination of interval-censored, right
censored and exact observations); the solid lines become dotted eventually to illus-
trate the idea of censoring i.e., the exact time of event is not known. (a) schematic
representation of the patients in D1 with solid green dots denoting “enrollment” (i.e.,
kidney donation) and green line (first solid and then dotted) denoting time from en-
rollment to either hypertension (black cross) or death (black asterisk); (b) schematic
representation of the manufactured hypothetical dataset, (c) schematic representa-
tion of the patients in D0 with solid blue dots denoting multiple “enrollments” and
blue line (first solid and then dotted) denoting time from an enrollment to either
hypertension or death.
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Figure 3.2(a) shows the same three patients as in Figure 3.1(a). Patients 1 and 2 have
their times to event interval censored. Patient 3, however, has an exact time of death
recorded. Figure 3.2(c) shows the same three patients as in Figure 3.1(c). Patients 1
and 2 have interval censored observations. The outcome for Patient 3 is right-censored
(marked by a black vertical bar). Figure 3.2(b) shows the manufactured hypothetical
dataset D∗ with censored observations.
In the presence of coarsening, additional assumptions are required to identify
P [T > t|Z = 1] and the distribution of P [T > t|W,Z = 0]. We will assume non-
informative censoring conditional Z and W (Gómez and others , 2004; Oller and oth-
ers , 2004).
3.2.3 Inference
Our inferential framework aims to contrast S1(t) and S0(t), under assumptions,
by using Equations (3.2) and (3.3) applied to the manufactured dataset D∗. The key
idea is to estimate P [T > t|Z = 1] and F (w|Z = 1) from the donors in D∗ and P [T >
t|W = w,Z = 0] from the non-donors in D∗. Let S1(t|w)
def
= P [T > t|W = w,Z = 1]
and S0(t|w)
def
= P [T > t|W = w,Z = 0]. Let n be the number of “enrollments” in
D∗. The observed data for each “enrollment” i in D∗ is [Ei, {Ti : Ei = 1}, {(Li, Ri] :
Ei = 0}, Zi,Wi], where Ei denotes the indicator of exactly observing the failure time,
Ti denotes the failure time observed when Ei = 1, and Li and Ri denote the left
and right endpoints of the interval in which the time to event is known to lie when
46
CHAPTER 3. CAUSAL EFFECT AMONG THE EXPOSED: MULTIPLE DATA
SOURCES AND CENSORED OUTCOMES
Ei = 0. For right censored observations, Li < ∞, Ri = ∞ and for interval-censored
observations Li < Ri <∞.
Under non-informative censoring and independence of “enrollments” in D∗, the





[{S1(Li|Wi)− S1(Ri|Wi)}1−Ei{(S1(Ti|Wi)− S1(Ti + ε|Wi))/ε}Ei ]Zi
[{S0(Li|Wi)− S0(Ri|Wi)}1−Ei{(S0(Ti|Wi)− S0(Ti + ε|Wi))/ε}Ei ]1−Zi
(3.4)
where ε is a specified constant. Note that the “enrollments” with exact observa-
tions contribute to the likelihood using a numerical approximation to the conditional
densities of T given W and Z = 1 and of T given W and Z = 0. The numerical
approximation is based on the negative of the numerical derivative of the respective
survival functions. The numerical derivatives involve the perturbation parameter ε
which we recommend setting to a small value relative to range of the survival times.
We assume a proportional hazards model (Cox, 1972) for S1(t|W ) and S0(t|W ).
Specifically, we assume (for z = 0, 1)
Sz(t|W ) = exp{−Λ0,z(t) exp(W ′βz)} (3.5)
where βz is the vector of regression parameters corresponding to the vector of co-
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variates W and Λ0,z(t) is the cumulative baseline hazard function. The cumulative
baseline hazard function Λ0,z(t) is modeled as a finite linear combination of inte-
grated spline basis functions (non-decreasing from 0 to 1) with non-negative coeffi-
cients (Wang and others , 2015). The advantage of this specification relative to one
that is nonparametric is a significant reduction in the dimension of the parameter
space while allowing for flexibility. The unknown parameters Λ0,z(t) and βz are esti-
mated by maximizing the likelihood in (3.4) subject to (3.5). Following the method
in Wang and others (2015), we obtain the maximum likelihood estimates Λ̂0,z(t) and
β̂z by a EM algorithm that involves a two-stage data augmentation with latent Pois-
son random variables. This method exploits the connection between the proportional
hazards model and a non-homogeneous Poisson process.
Plugging Λ̂0,z(t) and β̂z into Equation (3.5) we obtain an estimator of Sz(t|W )
denoted as Ŝz(t|W ). We estimate F (w|Z = 1) by its empirical distribution, denoted
as F̂ (w|Z = 1), based on the covariate information for patients with Z = 1 in D∗.
Since P [T > t|Z = 1] can be expressed as
P [T > t|Z = 1] =
∫
w
P [T > t|W = w,Z = 1]dF (w|Z = 1) (3.6)
we estimate P [T > t|Z = 1] by plugging Ŝ1(t|W ) and F̂ (w|Z = 1) into Equation
(3.6). We denote this latter estimator as P̂ [T > t|Z = 1] (Note: P [T > t|Z = 1]
can be alternatively estimated by the non-parametric Turnbull estimator (Turnbull,
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1976) that uses only the outcome information for patients with Z = 1.)
Plugging P̂ [T > t|Z = 1] into Equation (3.2) we obtain Ŝ1(t). We obtain Ŝ0(t)
from Equation (3.3) by plugging in Ŝ0(t|W ) and F̂ (w|Z = 1).
3.2.4 Measure of Treatment Effect
We measure the treatment effect by parsimoniously modeling the relationship
between the quantiles of S1(·) and S0(·). Specifically, we assume that S−11 (p) =
exp(δ)S−10 (p) for all 0 < p < 1. This model is equivalent to assuming, for patients
with Z = 1, an accelerated failure time (AFT) model (Wei, 1992) of the form:
log(T1) = log(T0) + δ (3.7)
Note that δ = 0 implies that S1(t) = S0(t) for all t, i.e. the donors have the same
distribution of time to event had they not donated.
We estimate δ using the following simulation procedure. Suppose that we are
interested in follow up through time τ . We obtain estimates Ŝ1(t) and Ŝ0(t) by the
method described in Section 3.2.3. We generate K observations T1,k ∼ Ŝ1(t) and
another K observations T0,k ∼ Ŝ0(t), k = 1, . . . , K. Let Uz,k = min(Tz,k, τ) and
∆z,k = I(Tz,k < τ) for z = 0, 1, k = 1, . . . , K. We then fit model (3.7) using these
data. Denote the resulting estimator of δ by δ̂. We use the R package aftgee (Chiou
and others , 2014) to fit this model and compute δ̂.
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3.2.5 Computation of Standard Errors and Confi-
dence Intervals
We compute estimates of standard error of δ̂ using nonparametric bootstrap of
individuals from the original datasets. In our analysis and simulations, we used 95%
Wald-based confidence intervals with the bootstrapped standard error estimator.
3.3 Data Analysis
We apply the methods developed in Section 3.2 to estimate the causal effect of
kidney donation on hypertension-free survival and diabetes-free survival among those
who chose to donate.
The donors were drawn from the Wellness and Health Outcomes in LivE Donors
(WHOLE-DONOR) Study. The earliest of the donations occurred in 1970 and the
latest in 2013. Age, gender, race, BMI were measured for each donor at the time of
donation. The donors included in the final analytic sample were free of the corre-
sponding disease endpoint at the time of donation. The non-donors were identified
from Atherosclerosis Risk in Communities (ARIC) (Visits 1-4; 1987-1998) and Coro-
nary Artery Risk Development in Young Adults (CARDIA) (Visits 1-8; 1985-2011)
studies. The non-donors included in the final analytic sample were free of the disease
endpoint at the first visit. The last available visit with non-missing disease ascer-
tainment was considered the “end visit”. The preceding visits where the subject is
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free of the disease endpoint of interest and other co-morbidities (e.g., cardiovascular
disease, cancer) were considered valid “enrollments”. Age, gender, race and BMI are
measured for each subject at each “enrollment”. Table 3.1 gives the demographic
information of the final analytic samples corresponding to each endpoint. Donors
tend to be older, more female, less black and have higher BMI than non-donors.
In the analyses, the cumulative baseline hazard functions were modeled using inte-
grated spline basis functions with five interior knots. The proportional hazards model
estimates were not sensitive to selection of the number of interior knots. Further, we
set τ = 20 years and K = 1000.
3.3.1 Hypertension-free analysis
In the final analytic sample, there are 1,077 live donors and 10,832 eligible non-
donors. The non-donors contribute multiple “enrollments” during follow-up. Among
the non-donors, 21%, 22%, 45% and 12% contributed 1, 2, 3 and 4 “enrollments”
respectively. Among the donors, 12.26% had interval censored observations, 76.42%
had right censored observations and 11.32% had exact observations. The percentages
of interval censored and right censored observations among the non-donor records
were 27.58% and 72.41% respectively.
Figure 3.3a shows the estimated cumulative baseline hazard function correspond-
ing to the reference cohort (age 42 years, female, black, BMI 25). Table 3.2 shows the
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(a) Endpoint: Hypertension or death (b) Endpoint: Diabetes or death
Figure 3.3: Estimates of cumulative baseline hazard function in the reference cohort
(age 42 years, female, black, BMI 25) for donors and non-donors for the endpoints
(a) hypertension or death, and (b) diabetes or death.
(a) Endpoint: Hypertension or death (b) Endpoint: Diabetes or death
Figure 3.4: Estimates of the donor survival curve, the counterfactual survival curve
and the Turnbull estimator among donors for the endpoints (a) hypertension or death,
and (b) diabetes or death.
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Table 3.1: Demographic information of the subjects in the final analytic sample
corresponding to each endpoint.
Endpoint
Hypertension Diabetes
or death or death
Donors Non-donors Donors Non-donors
Number of 1077 10,832 1192 9056
subjects
Number of 1077 26,597 1192 15,970
“enrollments”
Age
mean 44.32 42.54 44.56 41.17
(sd) (11.24) (14.58) (11.40) (15.03)
Female (%) 63 55 63 58
Black (%) 13 30 13 31
BMI
mean 26.43 25.89 26.55 25.10
(sd) (4.04) (4.76) (4.10) (4.45)
estimated regression coefficients from the PH Model. For donors and non-donors, age,
race and BMI were positively and significantly associated with the risk of developing
hypertension or dying; gender was not a significant risk factor. Figure 3.4a shows
the estimated donor and counterfactual survival curves. For comparative purposes,
the Turnbull estimator for donors is also presented. The treatment effect under the
AFT model is estimated to be 0.005 [95% CI: -0.10,0.12]. This result may be hard to
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Table 3.2: Point estimates and 95% confidence intervals for the regression coeffi-
cients obtained from separate PH models for each endpoint.
Hypertension Diabetes
or death or death
Covariate Donors Non-donors Donors Non-donors
Age
Point estimate 0.054 0.044 0.032 0.043
(95% CI) (0.041,0.066) (0.041,0.047) (0.009,0.056) (0.035,0.051)
Female
Point estimate -0.142 -0.070 -0.006 -0.292
(95% CI) (-0.392,0.109) (-0.14,0.0001) (-0.436,0.425) (-0.425,-0.158)
Black
Point estimate 0.509 0.581 0.470 0.687
(95% CI) (0.194,0.826) (0.503,0.659) (-0.164,1.105) (0.547,0.827)
BMI
Point estimate 0.067 0.057 0.073 0.067
(95% CI) (0.037,0.097) (0.05,0.063) (0.017,0.128) (0.055,0.079)
interpret due to the crossing of the estimated survival curves. Table 3.3 reports the
estimated differences (and associated 95% confidence intervals) between the donor
and counterfactual survival curves at 5, 10, 15 and 20 years. These analyses show
that there is no significant evidence to suggest that donors are putting themselves at
increased risk for hypertension or death.
3.3.2 Diabetes-free analysis
In the final analytic sample, there are 1,192 live donors 9,056 eligible non-donors.
The non-donors contribute multiple “enrollments” during follow-up. Among the non-
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Table 3.3: Point estimates and 95% confidence intervals for the difference in the
donor and counterfactual survival curves at particular time points for each endpoint.
Hypertension Diabetes
or death or death
Time(in years) Estimate (95% CI) Estimate (95% CI)
5 0.019 (-0.003,0.04) 0.011 (0.004,0.017)
10 0.016 (-0.02,0.053) 0.019 (0.001,0.036)
15 -0.019 (-0.07,0.032) -0.004 (-0.042,0.033)
20 -0.044 (-0.114,0.027) 0.002 (-0.078,0.081)
donors, 49%, 26% and 25% contributed 1, 2 and 3 “enrollments” respectively. Among
the donors, 3.10% had interval censored observations, 92.79% had right censored
observations and 4.11% had exact observations. The percentages of interval censored
and right censored observations among the non-donor records were 8.32% and 91.68%
respectively.
Figure 3.3b shows the estimated cumulative baseline hazard function correspond-
ing to the reference cohort (age 42 years, female, black, BMI 25). Table 3.2 shows the
estimated regression coefficients from the PH Model . For non-donors, age, race and
BMI were positively and significantly associated with the risk of developing diabetes
or dying; gender had a significant negative association. For donors, age and BMI were
positively and significantly associated with the risk of developing diabetes or dying;
gender and race were not significant risk factors. Figure 3.4b shows the estimated
donor survival and counterfactual survival curves; the Turnbull estimator for donors
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is also presented. The treatment effect under the AFT model is estimated to be -0.004
[95% CI: -0.15,0.14]. Like the hypertension analysis, the estimated survival curves
cross. Table 3.3 reports the estimated differences (and associated 95% confidence
intervals) between the donor and counterfactual survival curves at 5, 10, 15 and 20
years. At 5 and 10 years, there are statistically significant differences between the
donor and counterfactual survival curves, with donation appearing to be protective
for the occurrence of diabetes at these time points. At 15 and 20 years, the differences
are no longer statistically significant. Donation may be protective for diabetes/death
in the early years due possibly to better health care or healthy behavior. Such benefits
appear to dissipate in the long term.
3.4 Simulation Results
We conducted a simulation study to evaluate the performance of the proposed
methodology. We simulated 500 datasets that closely resembled the data structure
for the hypertension-free analysis discussed above. For each dataset, the number of
donors was 1,077 and the number of non-donors was 10,832.
3.4.1 Simulation of Donor Data
We generated independent covariates to mimic age, gender (1 = female, 0 =
male), race (1 = black, 0 = white) and BMI - age and BMI were simulated as normal
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random variables with means 44.32 and 26.43 and standard deviations 11.24 and
4.04, respectively, gender and race were simulated as Bernoulli random variables with
probabilities 0.63 and 0.13, respectively. Using the 4-dimensional covariate vector W ,
we generated, for each donor, an exact time-to-event from an exponential regression
model with rate λ exp(βTW ), λ = 0.01 and βT = (0.04,−0.15, 0.42, 0.06).
We introduced a censoring mechanism by independently generating four exam-
ination times, with the inter-examination times distributed according a truncated
exponential distribution with rate 0.25 and truncation at 6 years. When the time-
to-event was contained between two examination times, we, with probability 0.8,
interval-censored the outcome using the examination times as the end-points and,
with probability 0.2, considered the outcome to be exactly observed. If the time-
to-event was larger than the time to last examination time, we right-censored the
outcome at the last examination time.
3.4.2 Simulation of Non-Donor Data
For non-donors, we generate multiple visit data which will translate into multiple
“enrollments”. To start, we generated independent covariates to mimic age (at first
visit), gender(1 = female, 0 = male) and race (1 = black, 0 = white). Age was
simulated as a normal random variable with mean 42.54 and standard deviation 14.58.
Gender and race were simulated as Bernoulli random variables with probabilities
0.55 and 0.30, respectively. For each non-donor, we generated a random variable V ,
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denoting the number of clinic visits (assumed to range from 1 to 4). The probability
distribution of V was specified as follows: P [V = 1] = 0.21, P [V = 2] = 0.22, P [V =
3] = 0.45, P [V = 4] = 0.12. The duration of time between visits was generated
according to a truncated exponential distribution with rate 0.1 and truncation at 20
years. We also generated a (V + 1)th clinic visit using this inter-visit distribution.
Since age is time-varying, we set the age at a given visit to be the age at the first
visit plus the time that has elapsed between the given visit and the first visit. We
generated BMI at each visit according to a linear mixed effects model with gender,
race and visit-specific age as fixed covariates, a fixed intercept, a subject-specific
normally-distributed, mean zero random effect and normally-distributed, mean zero
random noise. The intercept was set to 17.62, the coefficients for gender, race and
age were set to -0.26, 3.04 and 0.17, respectively, and the standard deviations of the
random effect and random noise were set to 4.61 and 1.53, respectively.
Our censored outcome data generation process proceeds sequentially by clinic
visit. At each visit v = 1, . . . , V (let tv be the time of this visit), we generated,
using the 4-dimensional covariate vector W (i.e., age, gender, race, BMI) available
at this visit, an exact time-to-event from an exponential regression model with rate
λ exp(δ) exp(βTW ), where λ and βT are the same as specified for the donors and δ
is a parameter that differentiates the conditional risk of the event between donors
and non-donors. It is important to note that our specification of the exponential
regression models for the donors and non-donors implies that (3.7) holds. In our
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simulation study, we considered δ = −0.5, 0, 0.5. If the exact time-to-event is less
than the time to the next visit (let tv+1 be the time of this visit), we (1) interval
censored the outcome with zero as the left endpoint and the time between visit v
and visit v + 1 (i.e., tv+1 − tv) as the right endpoint, (2) stopped the data generation
process, and (3) for each previous visit p = 1, . . . , v − 1 (let tp be the time of this
visit), we produced an additional enrollment, where the censored outcome has left
endpoint tv − tp and right endpoint tv+1 − tp; otherwise we continued to the next
clinic visit. If visit V is reached and the exact time-to-event is not less than the time
of visit V + 1, then we created for each visit v = 1, . . . , V , right censored enrollments
with right censoring time tV+1 − tv.
3.4.3 Simulation Results
Table 3.4 shows the results of the simulation study, based on 500 simulated
datasets. We considered three choices of δ = −0.5, 0, 0.5. For all choices, the bias
in estimation of δ is very small and the confidence intervals (constructed using 1000
bootstrap samples) achieve the nominal 95% level. The average of the bootstrapped
standard errors of δ̂ across simulated datasets is approximately equal to the standard
deviation of δ̂’s across these datasets. Overall, the results indicate that the proposed
methods perform well in this simulation study.
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Table 3.4: Simulation results.
δ Bias Standard Average Empirical
deviation standard error coverage
-0.5 0.008 0.07 0.07 0.96
0 0.005 0.07 0.07 0.95
0.5 0.002 0.07 0.07 0.95
3.5 Discussion
In this paper, we developed an inferential framework for estimating the causal
effect among “exposed” subjects on a time-to-event outcome, based on multiple data
sources and censored outcome information. This was achieved by conceptualizing and
manufacturing a point exposure study that allowed us to identify the causal parameter
of interest under certain set of assumptions (i.e., no unmeasured confounders, non-
informative censoring).
In our motivating example, the time-to-event outcome was censored in the broad-
est sense. That is, it was a mix of interval-censored, right-censored and exact obser-
vations. With the exception of two working papers (Vandebosch and Goetghebeur,
2005; Valappil and others , 2015), we were not able to identify any published causal in-
ference papers with interval-censored outcomes. Our approach relied on specification
of a proportional hazards regression model (Cox, 1972). For this model, inference in
the presence of interval censoring has been well-studied (see, e.g., Finkelstein, 1986;
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Satten, 1996; Goggins and others , 1998; Satten and others , 1998; Pan, 1999, 2000;
Goeteghebeur and Ryan, 2000; Betensky and others , 2002; Cai and Betensky, 2003;
Zhang and others , 2010; Wang and others , 2015 for frequentist approaches and Sinha
and others , 1999; Yavuz and Lambert, 2011; Wang and others , 2013; Lin and others ,
2015 for Bayesian approaches). In our setting (large number of subjects, some with
exact observations), the majority of these approaches are too computationally ex-
pensive or too technically complicated to practically implement. Before adapting the
approach of Wang and others (2015), we experimented with the R packages intcox
and coxinterval. The package intcox adopts the iterative convex minorant ap-
proach of Pan (1999) but it also produces biased parameter estimates as pointed out
by Wang and others (2015). The package coxinterval developed based on Boruvka
and Cook (2015) could not be easily adapted to handle exact observation times.
Our analysis can be prone to bias if the underlying assumptions (i.e., no unmea-
sured confounding, non-informative censoring) are violated. In terms of assumptions,
we are most concerned about the no unmeasured confounding assumption. Our abil-
ity to adjust for measured confounding factors is limited by the fact that we require
that all data sources record data on the same set of factors. In our analysis, we ad-
justed for gender, race, age and BMI which were well recorded in live donor database
and the ARIC and CARDIA studies. However, it is likely that there are additional
confounding factors at play, e.g., blood pressure and glomerular filtration rate. While
these factors were to be recorded in the multiple datasets, they have missing data
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rates of the order of 15%. In future work, we plan to extend our methods to handle
this issue.
Another limitation of our methodology is model specification. Specifically, our
analysis relies on correct specification of proportional hazards regression models for
the time-to-event for donors and non-donors. This may lead to some bias in the
estimate of the target causal parameter. In a future work, we plan to explore meth-
ods that are more robust to such misspecification. Our proposed estimator of the
treatment effect relies on an accelerated failure time model that connects the donor
and counterfactual survival times. This assumption may not hold, especially in set-
tings whether the associated survival curves cross. Nonetheless, the estimator can
be thought of as the best fitting accelerated failure time model that is consistent
with the estimated survival curves. Future work will explore alternative methods for
contrasting the survival curves.
In evaluating exposure effects, it is not uncommon for information on exposed
and non-exposed subjects to be obtained from different data sources. The methods
developed in this paper should be useful for evaluating such effects, provided that
(1) one can conceptualize a hypothetical point exposure study and (2) the underlying
data sources collect a common set of confounding factors.
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Chapter 4
Testing Equality of Curves After
Covariate Adjustment
4.1 Introduction
We propose simple methodological approaches for global and local tests of the
difference between the mean of treatment and control groups when the measured
outcome is a function. Several papers in the functional data analysis literature have
focussed on comparing the averages of two functional processes. For example, Benko
and others (2009) developed bootstrap-based tests of equality of means, eigenval-
ues and eigenfunctions of the covariance function in the two sample problem. Hall
and Keilegom (2007) used bootstrap-based tests for equality of distributions of two
independent samples of curves. Zhang and others (2010) proposed L2-based and
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bootstrap-based statistics for testing equality of two average curves when the subject
specific curves are independent and observed without noise. Crainiceanu and others
(2012) proposed a bootstrap-based inference procedure for the difference in means
of two correlated functional processes. However, none of these approaches consid-
ered covariate-adjusted testing, which is essential in cases when covariates may differ
across groups. Several authors have developed Bayesian approaches for this problem
in settings with complex correlation structures (Behseta and Kass, 2005; Behseta and
others , 2007; Morris and others , 2003; Morris and Carroll, 2006; Morris and others ,
2006, 2011).
The scientific problem that motivated our study is whether targeted deletion of
interleukin 10 gene (IL-10tm1Cgn) in mice leads to decrease in oxygen consumption
of the animal. We have repeated measures of oxygen consumption in a group of 10
mice where the gene has been knocked out and a control group of 10 mice where
the gene is present. The measurements were taken at regularly spaced time points
over four days. We want to explore if the average oxygen consumption through the
day (midnight-midnight) differ significantly between the groups and if the genotype-
outcome association is altered by the body composition of the animal. The novelty of
our approach is that it addresses the problem that each animal has repeated functional
measurements over multiple days (oxygen consumption measure at every 30 minutes
for 4 days) and additional covariates of interest (i.e., body composition measures).
We develop a permutation based approach to test for a global difference between
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the averages of two functional processes after covariate adjustment using the estimated
L2 area under the squared difference curve as the test statistic. We also test for lo-
calized differences between the two covariate adjusted average curves using the 95%
pointwise and joint confidence intervals obtained using a nonparametric bootstrap
of subjects. The main novelty of our paper is that we are using the covariate ad-
justed curves to develop the test procedures and take into account the within-subject
sampling functional correlation. The proposed approach is easy-to-implement, com-
putationally fast and scalable and adaptable to more complex settings. In Section 4.2
we develop the statistical framework for our method. Section 4.3 provides the results
of the real data analysis and the simulation study. We conclude with a discussion in
Section 4.4.
4.2 Methods
Our method utilizes information from two data sources having similar structure:
the first one comes from “treated” animals (e.g., IL10tm group) and the second one
comes from animals who are “not treated” (e.g., control group). Both data sources
have information on a functional outcome [e.g., oxygen consumption measured at reg-
ular intervals (∼30 minutes) over a period of time (4 days)] and baseline covariates
(e.g., body composition measures). Figure 4.1 displays the scatter plots for oxygen
consumption of the animals in each group in a 24 hour period (midnight-midnight)
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Figure 4.1: Plot of oxygen consumption during the 24 hours over multiple days;
the panels in the left correspond to animals in the control group and panels on the
right correspond to animals in the IL-10tm1Cgn group. Each panel shows the oxygen
consumption of an animal over 4 days: Day 1 (black line), Day 2 (red line), Day 3
(blue line) and Day 4 (green line).
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over 4 days. Figure 4.2 displays the average oxygen consumption (over every observa-
tion within days and all four days) as a function of body mass composition as well as
the body mass composition distribution within treatment group. Let ni denote the
number of animals in the ith group, i = 0 for “treated” animals and i = 1 for “not
treated” animals. We observe {(Yijl(t), Xij) : t = t1, . . . , tk; i = 0, 1; j = 1, . . . , ni; l =
1, 2, 3, 4}, where Yijl(t) denotes the functional outcome observed at the time points
t1, . . . , tk in the range [0, T ] during the l
th day and Xij denotes the vector of baseline






are interested in a model of the type:
Yij.(t) = βi0(t) +Xijβi1(t) + εij(t) (4.1)
where εij(t) is a mean zero process with unspecified correlation structure. We want
to test the hypothesis: µ1(t) = µ0(t), where µi(t) = E[Yij.(t)] for i = 0, 1. Note that
µi(t) = E[Yij.(t)] = E[E[Yij.(t)|Xij]] = βi0(t) + βi1(t)E[Xij]. We model the functional
regression parameters in equation 4.1 using P-splines that combine a B-spline basis
with a discrete penalty on the basis coefficients (Eilers and Marks, 1996). The re-
gression functions are estimated using restricted maximum likelihood estimation of
the associated penalized least squares objective function in the framework of general-
ized additive models (Chambers and Hastie, 1991; Hastie and Tibshirani, 1990). For
i = 0, 1 we estimate µi(t) by µ̂i(t) = β̂i0(t) + β̂i1(t)Ê[Xij], where Ê[Xij] is the sample
67
CHAPTER 4. TESTING EQUALITY OF CURVES AFTER COVARIATE
ADJUSTMENT
average of the covariates in the ith group. We are making the working assumption
that εij(t) are independent. This assumption substantially simplifies the estimation
procedure, though for inference we will take the within-subject correlation into ac-
count. Estimating parameters under independence and then correcting the confidence
intervals has a long and successful history in statistics.
4.2.1 Test for Global Difference
Define δ(t) = µ1(t) − µ0(t) and denote by I =
∫ T
0
δ2(t)dt. Note that δ(t) = 0
for every t if and only if I = 0. Thus I is a measure of global difference between
the means of the two groups. Denote the estimates of the within group averages by
µ̂i(t), i = 0, 1 and let δ̂(t) = µ̂1(t)−µ̂0(t) be an estimator of δ(t). We estimate I by the





δ̂2(wi), where w0 = 0, w1, . . . , wK = T
is a fine grid of equally spaced points on [0, T ] and K is a large number. We consider
the null hypothesis: H0 : I = 0 versus the alternative hypothesis Ha : I > 0. Our
permutation based test procedure involves the following steps:
(i) Consider the joint dataset with n = n1 + n0 animals, where for i = 0, 1, ni
animals come from ith group. Consider a random permutation p of the labels
of “treatment” (i.e. “treated” or “not treated”).





0 (t) by the model fitting and estimation procedure described earlier. Denote
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0 (t) and the integral of the squared
difference function by Ip. Compute Îp by the method described earlier.
(iii) Repeat step (i) with P permuted datasets.
(iv) Compute the permutation test p-value to be the proportion of permutations
with Îp ≥ Î.
The key idea of the permutation test is as follows: under the null hypothesis there is
no difference in the average outcome between the two groups. Hence the treatment
labels are exchangeable under the null hypothesis. The empirical distribution of Îp
estimates the distribution of the global difference between the two groups under the
null hypothesis. This provides the rationale for the computation of the test p-value
in step (iv).
4.2.2 Test for Localized Differences
We also propose a test for localized differences between groups, (i.e., the difference
in average outcome at particular time points) using a nonparametric bootstrap-based
inferential procedure (Crainiceanu and others , 2012). The main difference from the
procedure in Crainiceanu and others (2012) is that we are working with covariate
adjusted curves, which is important in many applications.
One question of interest is whether there is a difference in the average outcomes
between the groups at a fixed time point t. The corresponding null and alternative
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hypotheses can be stated as:
H0,t : µ1(t) = µ0(t) versus Ha,t : µ1(t) 6= µ0(t) for a fixed t (4.2)
We compute the 95% pointwise confidence intervals to address this question.
Another question of interest is whether there is a difference between the average
curves at all time points. The corresponding null and alternative hypotheses are as
follows:
H0,m : µ1(t) = µ0(t) ∀t versus Ha,m : µ1(t) 6= µ0(t) for at least one t (4.3)
This question can be addressed using the 95% joint confidence intervals to account
for multiple hypotheses testing.
The key steps in the computation of the different kind of confidence intervals are
as follows:
(i) Generate B simple random samples with replacement separately from each
group.
(ii) For each bootstrap dataset, define δb(t) = µ1b(t)−µ0b(t), b = 1, . . . , B. Estimate
µ1b(t), µ0b(t), and δb(t) by the procedure described earlier.
(iii) Compute 95% pointwise and joint confidence intervals.
The 95% pointwise confidence intervals in step (iii) are constructed based on the
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bootstrap distribution of δb(t) for a fixed t. More specifically, we estimate the standard
error of the difference of means based on the bootstrap samples and use the z-score
cutoff. They can be interpreted as follows: at each time point t in repeated samples
the true difference will be covered by the interval 95% of the time. The 95% joint
confidence intervals are computed by the algorithm given in Section 3 of Crainiceanu
and others (2012). The interpretation is as follows: at all time points in repeated
samples the true difference will be covered by the interval 95% of the time.
4.3 Results
A mouse with targeted deletion in the interleukin 10 gene (IL-10tm1Cgn) has been
proposed as a mouse model for frailty and low-grade inflammation. The older frail
IL-10tm mice show many similarities with older frail human beings. This provides the
rationale for using it as a scientific model for studying frailty. It has been hypothesized
that older, frail mice have decreased oxygen consumption compared to the normal
wildtype mice. We use the methods developed in the Section 4.2 to explore the validity
of this hypothesis and to investigate whether the statistical association between the
genotype and decreased oxygen consumption is altered by the body composition of
the animal.
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4.3.1 Description of study design and data
We have experimental data on n0 = 10 mice with the interleukin 10 gene knocked
out (IL-10tm group) and n1 = 10 additional mice where the gene is present (con-
trol group). For the animals in each group we have repeated measures of oxygen
consumption per gram body weight (every 30 mins over 4 consecutive days; 116 re-
peated observations for each animal, cf Figure 4.1). We also have information on
body composition measures (body weight, lean mass, fat mass, fluid mass) for each
animal obtained through Nuclear Magnetic Resonance (NMR) experiments. We want
to compare the average daily oxygen consumption curves between the groups after
adjusting for body composition measures.
4.3.2 Exploratory Analysis, Outlier Identification
and Covariate Adjustment
Figure 4.2 displays the bivariate distributions of oxygen consumption and the lean
mass and fat mass in the two genotype groups. The upper panel includes observa-
tions at all time points as the dependent variable. The lower panel uses the average
oxygen consumption over time as the dependent variable. For illustrative purposes
we used thin plate regression spline smoothing with four basis functions. The oxygen
consumption vs fat mass relationship is similar in two genotype groups. However,
there is a difference in the oxygen consumption vs lean mass relationship between the
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two genotype groups.
Figure 4.3 displays the relationship between lean mass and fat mass for both
groups of animals using a thin plate regression spline smoother with four basis func-
tions. We identified one outlying animal in the IL-10tm group with lean mass 22.4
grams and fat mass 1.7 grams. The striking difference in the nature of the red curve
in the upper and lower panel of Figure 4.3 supports this fact. In addition to the
main analysis (Analysis I) that includes all the animals, we also perform a sensitivity
analysis excluding this outlying animal (Analysis II).
Figure 4.4 displays the bivariate distribution of oxygen consumption and the ratio
of fat mass and lean mass in the two genotype groups for both Analyses I and II.
The upper panel includes observations at all time points as the dependent variable.
The lower panel uses the average oxygen consumption over time as the dependent
variable. We use thin plate regression splines with four basis functions to smooth the
data. The animals in the IL-10tm group have lower values of the ratio of fat mass and
lean mass compared to the animals in the control group. These plots also indicate
that one animal may be an outlier.
The exploratory analyses indicate that the ratio of fat mass and lean mass is a
key body composition measure that could potentially mediate the association between
genotype and oxygen consumption. For the rest of the analysis, we use the empirical
average of the oxygen consumption at a particular time over the four days as our
functional outcome and the ratio of fat mass and lean mass as the scalar covariate
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Figure 4.2: Bivariate relationship of oxygen consumption with lean mass and fat
mass in the two genotype groups (black color for control group and red color for
IL-10tm group): in the upper panel the dependent variable is observed oxygen con-
sumption at all time points; in the lower panel the dependent variable is average
oxygen consumption over time.
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Figure 4.3: Relationship between lean mass and fat mass in the two genotype
groups (black color for control group and red color for IL-10tm group): upper panel
corresponds to Analysis I (n = 20, n0 = 10, n1 = 10) with the outlier, lower panel
corresponds to Analysis II (n = 19, n0 = 9, n1 = 10) without the outlier.
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Figure 4.4: Bivariate relationship of oxygen consumption with ratio of fat mass and
lean mass in the two genotype groups (black color for control group and red color
for IL-10tm group) for both Analysis I (n = 20, n0 = 10, n1 = 10) and Analysis II
(n = 19, n0 = 9, n1 = 10): in the upper panel the dependent variable is observed
oxygen consumption at all time points; in the lower panel the dependent variable is
average oxygen consumption over time.
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of interest. The covariate adjusted curves are computed by the methods described in
Section 4.2. To investigate the potential mediation hypothesis, we compare results
with the approach that normalizes the outcome by per gram body weight. The latter
approach is routinely applied in studies of mouse metabolism (Speakman, 2013).
4.3.3 Global Genotype Effect
We follow the permutation based approach outlined in Section 4.2.1 to test for
global genotype effect. We estimate the global difference over a fine grid on the
range [0,24 hours] (i.e., midnight-midnight) where the time points are 0.01 hours
apart. We compute the p-value based on 1000 permutations. Note that when we use
the body weight normalized outcome the permutation test results provide evidence
for significant global genotype effect (p-value = 0.01). However, after adjusting the
outcome with the ratio between fat mass and lean mass, there is no such evidence
(p-value = 0.19).
4.3.4 Localized Genotype Effect
Figure 4.5 displays the point estimates and the 95% pointwise and joint confidence
intervals for the difference in average oxygen consumption between the control mice
and the IL-10tm mice. The results are based on B = 1000 bootstrap samples. When
the oxygen consumption is normalized per gram of body weight (left panel) we observe
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a significant decrease in average oxygen consumption at different times during the
day for the IL-10tm mice compared to the control mice. However, when oxygen
consumption is adjusted for the ratio of fat mass and lean mass of the animal, the
difference is no longer statistically significant.
Both Analyses I and II resulted in similar findings, indicating that results are
not strongly influenced by the one outlier identified in the exploratory process. The
results in Sections 4.3.3 and 4.3.4 provide evidence that supports the hypothesis that
the association of interleukin 10 gene deletion on the average oxygen consumption is
mediated by the ratio of fat mass and lean mass of the animal. The total computation
time for performing the tests for global genotype effect and localized genotype effect
was around 10 mins (Quad Core Processor 2.2 GHz, 8 GB RAM Macbook Pro)
4.3.5 Simulation Results
We investigate the performance of the proposed methods in a simulation study.
For different settings we generate 500 datasets from Model 4.1 with a single covariate,
for different choices of βi0(t) and βi1(t). We consider a time grid of 100 equally spaced
points in the interval [0,1]. We generate εij(t) in Model 4.1 from a Gaussian Process
distribution characterized by the equation ε(t) =
4∑
k=1
ξkφk(t) where ξk are mutually
independent N(0, λk) for k = 1, 2, 3, 4 and λk and φk(t) represent the k
th eigenvalue
and eigenfunction respectively of the functional principal component decomposition
of a centered and scaled version of outcome data. We consider different settings that
78
CHAPTER 4. TESTING EQUALITY OF CURVES AFTER COVARIATE
ADJUSTMENT
Figure 4.5: Plots showing 95% pointwise and joint confidence intervals for the
difference in mean oxygen consumption between control mice and IL-10tm mice: in
the left panel the oxygen consumption is normalized by body weight (BW) and in
the right panel the oxygen consumption is adjusted for the ratio of fat mass and lean
mass (FM/LM) of the animal.
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Table 4.1: Simulation results: Scenario 1 corresponds to β00(t) = β10(t) = 5
and β01(t) = β11(t) = 0.2 and covariate distribution in both the groups same as
in the control group of the motivating example; Scenario 2 corresponds to β00(t) =
β10(t) = sinπt, β01(t) = β11(t) = 0.2 and covariate distribution in both the groups
same as in the control group of the motivating example; Scenario 3 corresponds to
β00(t) = 5, β10(t) = 5.4 and β01(t) = β11(t) = 0.2 and covariate distribution in
both the groups same as in the control group of the motivating example; Scenario
4 corresponds to β00(t) = 0.1(1 + t)
2, β10(t) = 0.5(1 − t)2 and β01(t) = β11(t) = 0.2
and covariate distribution in both the groups same as in the control group of the
motivating example.
Global Test Local Test
1 - α Scenario n P̂ ÎACP ÎACJ
0.95 1 10 0.05 0.89 0.87
20 0.04 0.92 0.92
50 0.05 0.94 0.94
100 0.05 0.95 0.95
2 10 0.05 0.88 0.85
20 0.04 0.92 0.9
50 0.05 0.94 0.93
100 0.05 0.95 0.95
3 10 0.79 0.89 0.87
20 0.99 0.92 0.92
50 1 0.94 0.94
100 1 0.95 0.95
4 10 0.65 0.89 0.87
20 0.99 0.92 0.91
50 1 0.94 0.94
100 1 0.95 0.95
80
CHAPTER 4. TESTING EQUALITY OF CURVES AFTER COVARIATE
ADJUSTMENT
combine the choices of the following parameters:
1. Number of subjects: consider n1 = n0 with n = n1 + n0 and take n =
10, 20, 50, 100.
2. For the regression functions consider two scenarios for data generated under the
null hypothesis i.e., δ(t) = 0: (i) β00(t) = β10(t) = 5 and β01(t) = β11(t) = 0.2
and generate covariate from the same distribution for each group (e.g., we use
empirical distribution of the covariate values in the control group); (ii) β00(t) =
β10(t) = sin πt, β01(t) = β11(t) = 0.2 and generate covariate from the same
distribution for each group (e.g., we use empirical distribution of the covariate
values in the control group); two additional scenarios for data generated under
the alternative hypothesis i.e., δ(t) 6= 0: (iii) β00(t) = 5, β10(t) = 5.4, β01(t) =
β11(t) = 0.2 and generate covariate from the same distribution for each group
(e.g., we use empirical distribution of the covariate values in the control group);
(iv) β00(t) = 0.1(1 + t)
2, β10(t) = 0.5(1− t)2, β01(t) = β11(t) = 0.2 and generate
covariate from the same distribution for each group (e.g., we use empirical
distribution of the covariate values in the control group).
For the test of global differences, let P be the conditional probability that the null
hypothesis is rejected given the true data generating mechanism. When data are
generated under the null hypothesis, P is the probability of type I error. When
data are generated under an alternative hypothesis, P is the power of the test under
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that particular alternative. We estimate P by P̂ , the proportion of the simulated
datasets for which the test procedure rejects the null hypothesis (i.e., permutation
test p-value < 0.05). For the test of localized differences we estimate the integrated
actual coverage for pointwise confidence intervals (IACP ) and the integrated actual
coverage for joint confidence intervals (IACJ) as described in Crainiceanu and others
(2012).
The global test produces the right Type I error for a sample size as little as n = 10
as shown in the scenarios 1 and 2 in Table 4.1 where data are generated under δ(t) = 0.
In scenarios 3, 4 data are generated under δ(t) 6= 0. For scenario 3, the global test
rejects the global null hypothesis 79% of the 500 tests when the sample size is n = 10.
This improves with increasing sample size; for n = 20 the global null hypothesis is
rejected 99% of the tests and for larger sample sizes (i.e., n = 50, 100) it is rejected
in all cases. For scenario 4, the global null hypothesis is rejected in only 65% of the
cases for n = 10. For higher sample sizes (n = 20, 50, 100) the characteristics are
similar to Scenario 3. The 95% pointwise and joint confidence intervals suffer from
under-coverage for the case n = 10 but coverages improve with increasing sample
size.
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4.4 Discussion
In this paper, we provide simple and fast methods for testing if and where two
covariate adjusted average curves are different.
One question we wanted to explore was whether there is an overall difference
between the covariate adjusted curves. We develop a simple easy-to-implement and
novel test procedure by adapting the permutation test idea to functional outcomes.
To the best of our knowledge, this is the first time such an approach is being proposed
in the context of testing equality of two curves after covariate adjustment. We also
propose a test for localized difference between the genotype groups (i.e., difference
in average outcome at particular time points) using a non-parametric bootstrap of
subjects (Crainiceanu and others , 2012). The methods in Crainiceanu and others
(2012) were developed for a matched case-control study. The major difference between
our approach and the one presented in Crainiceanu and others (2012) is that we are
working with covariate adjusted curves.
The issue of covariate adjustment is of great importance in most of the scientific
problems for reducing the variability and adjusting for baseline imbalances. For in-
stance, Figure 4.4 shows that the two genotype groups differ significantly with respect
to the ratio of fat mass and lean mass. One of the strengths of our approach is that
the we perform the covariate adjustment in a statistically principled way: we first
model the relationship of the oxygen consumption function and the ratio of fat mass
and lean mass using restricted maximum likelihood based functional regression meth-
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ods; and then use the estimated regression functions and the within group sample
averages of the covariate to estimate the within group average oxygen consumption.
One issue of concern is that the empirical distribution of the ratio of fat mass and
lean mass has limited overlap between the genotype groups.
The global test shows good performance in the simulation studies in terms of Type
I error and power. However, the 95% point-wise and joint confidence intervals suffer
from under-coverage for low sample sizes (e.g., n = 10); but the coverage improves
with increase in sample size. For the 95% point-wise confidence intervals, if we use
the cutoff based on t distribution with (n/2 − 1) degrees of freedom as opposed to
the regular z-score cutoff, we get substantial improvement in coverage for the case
n = 10 and n = 20 under all scenarios. For higher sample sizes (i.e. n = 50, 100) the
coverages with t distribution cutoff and z−score cutoff assume similar values and this
finding is also consistent across all scenarios. The algorithm in Crainiceanu and others
(2012) for producing joint confidence intervals assumes multivariate normality of the
difference function. We tried other options, e.g., using a multivariate t distribution
with (n/2 − 1) df or the empirical distribution based on bootstrap as suggested by
Crainiceanu and others (2012). However, both these approaches result in marginal
improvement in coverage of the joint confidence intervals for low sample sizes (e.g.,
n = 10). In a future work, we plan to develop methods to handle this issue.
We also explored the sensitivity of the developed methods to outliers. The ex-
ploratory analyses have identified one outlying animal in the IL-10tm1Cgn group. We
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performed a sensitivity analysis by excluding this animal. However, the results were
very similar to the main analysis. Thus outlying animal does not strongly impact the
findings.
In summary, the key advantages of this method are its ease of implementation,
efficiency and scalability. Although it is targeted to address the scientific question
posed by the specific application, it can be adapted to a wide variety of biomedical




In this dissertation, we followed the scientific discovery process (Langley, 1987).
First, we identified, via collaborations, important scientific questions and the data
sources available. The questions included:
1. Do asthma and obesity have a common genetic risk factor (i.e., ORMDL3 locus
on Chromosome 17)? (Chapter 2)
2. Are kidney donors at risk for adverse health consequences (e.g., hypertension
or diabetes)? (Chapter 3)
3. Do mice with targeted deletion of interleukin 10 gene (IL-10tm1Cgn) have de-
creased oxygen consumption compared to normal wildtype mice? (Chapter 4)
Our approach to answering these questions was affected by the available data. In
fact, a common feature in addressing each of these questions was that information
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was required from multiple data sources.
Second, we translated each scientific question into an inferential problem involv-
ing an appropriate statistical parameter. Third, we investigated what can be learned
about the parameter of interest from information available from the observed data.
Often this information was not sufficient to learn about the true value of the pa-
rameter and additional untestable “identification” assumptions were required. It is
important that these assumptions be developed in close collaboration with subject
matter experts in order to judge their plausibility. While these assumptions are suf-
ficient to learn about the true value of the parameter in an infinite data setting, we
also needed to make additional testable assumptions to ensure that inferences in the
finite data setting are reasonably precise.
Fourth, we developed strategies for estimation of the parameters and characteriz-
ing their uncertainties. This step involved development of novel inferential methods
that combine information from multiple data sources in a statistically principled way.
The parameter estimates and associated uncertainties are then used to statistically
answer the scientific questions. In particular, the data (plus assumptions) may or
may not provide an affirmative answer to the questions. Either way, the result may
lead to new questions or theories, which will ideally lead to new discoveries.
In summary, statistical inference procedures using multiple data sources have enor-
mous potential within the scientific discovery process. We believe that the ideas de-
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causal inference perspective.
Biostatistics Journal Club: Department of Biostatistics, Johns Hop-
kins Bloomberg School of Public Health, Baltimore, MD, USA.
8. Apr 2014: Pal Choudhury, P., Scharfstein, D. O., Sen, S. Enhancing genetic
case-control studies using sample surveys.
Student Paper Competition: Probability and Statistics Day 2014,
University of Maryland, Baltimore County, Arbutus, MD, USA.
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9. Mar 2014: Pal Choudhury, P., Scharfstein, D. O., Sen, S. Enhancing genetic
case-control studies using sample surveys.
Contributed Talk: ENAR 2014. Baltimore, MD, USA
10. Jan 2014: Pal Choudhury, P., Scharfstein, D. O. Mendelian randomization:
a review from a causal inference perspective.
Invited Talk: Applied Statistics Unit Seminar, Indian Statistical In-
stitute, Kolkata, India
11. Dec 2013: Pal Choudhury, P., Scharfstein, D. O., Schwartz, B. Analyzing
the Causal Effect of Cumulative Lead Dose on Cognitive Function.
Causal Inference Seminar: Department of Biostatistics, Johns Hop-
kins Bloomberg School of Public Health, Baltimore, MD, USA.
12. Oct 2013: Pal Choudhury, P., Scharfstein, D. O., Sen, S. Enhancing genetic
case-control studies using sample surveys.
Causal Inference Seminar: Department of Biostatistics, Johns Hop-
kins Bloomberg School of Public Health, Baltimore, MD, USA.
13. Jan 2013: Pal Choudhury, P., Scharfstein, D. O. On analysis of studies with
missing venography data.
Invited Talk: Applied Statistics Unit Seminar, Indian Statistical In-
stitute, Kolkata, India.
14. Dec 2012: Pal Choudhury, P., Scharfstein, D. O., Sen, S. Enhancing genetic
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case-control studies using sample surveys.
Contributed Talk: Eighth International Triennial Calcutta Sympo-
sium on Probability and Statistics, University of Calcutta, Kolkata,
India.
15. Jun 2009: Pal Choudhury, P. and others. Analysis of women drop-out rate
in India.
Project Presentation: Department of Higher Education, Ministry of
Human Resource and Development, Govt. of India, New Delhi, India.
16. Aug 2008: Pal Choudhury, P., Bagchi, P. , Sengupta, S., Ghosh, A. On effect
of compromised nodes on security of wireless sensor network.
Invited Talk: National Workshop on Cryptology 2008, University of
Hyderabad, Hyderabad, India.
17. Jul 2008: Pal Choudhury, P., Chakravarti, A. Sampling rare alleles by se-
quencing individuals and populations.
Project Presentation: Institute of Genetic Medicine, Johns Hopkins
University School of Medicine, Baltimore, MD, USA.
18. Dec 2007: Pal Choudhury, P., Bambardekar, K. Biology of malaria para-
sites: plasmodium infected red blood cells under the action of optical tweezers.





• American Statistical Association (ASA)
• International Indian Statistical Association (IISA)
Honors and Awards
• 2014: Second Best Paper Award in the Graduate Students Oral Presentations
at 8th Annual Probability and Statistics Day at University of Maryland Balti-
more County.
• 2012: Joseph Zeger Travel Award for presenting the paper “Enhancing Ge-
netic Case-Control Studies Using Sample Surveys” at the Eighth International
Triennial Calcutta Symposium on Probability and Statistics, Kolkata, India.
• 2008: Summer Travel Awards from Sir Dorabji Tata Trust, Mumbai, India for
traveling to the Johns Hopkins University, Baltimore, MD, USA and pursue
research internship in Statistical Genetics.
• 2005: M. P. Birla Foundation Award for bagging 4th place in my school (among
500 students) and 13th place in my state (among 394,636 students) in the school
leaving examinations (Absolute aggregate score percentage: 95.4).
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Parichoy Pal Choudhury is starting as a Post-
doctoral Research Fellow in Biostatistics with Dr. Ni-
lanjan Chatterjee (Bloomberg Distinguished Professor
of Biostatistics and Oncology) at the Johns Hopkins
University from January 2016. He will be working at
the interface of causal inference, statistical genetics and disease risk modeling.
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